Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
A study for patients with confirmed locally advanced or metastatic Transitional Cell
Carcinoma of the bladder or upper urinary tracts who have developed progressive disease
within 12 months of their platinum based chemotherapy. The study aims to compare the overall
response rate of cabazitaxel treatment versus best supportive care including single agent
chemotherapy.